Depression of tumor necrosis factor-α, interleukin-6, and Interleukin-10 production:: A reaction to the initial systemic hyperactivation in septic shock

被引:19
作者
Haupt, W
Zirngibl, H
Riese, J
Stehr, A
Linde, HJ
Hohenberger, W
机构
[1] Universitat Erlangen Nurnberg, Chirurg Klin, Dept Surg, D-91054 Erlangen, Germany
[2] Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany
[3] Univ Regensburg, Dept Microbiol & Hyg, D-8400 Regensburg, Germany
关键词
septic shock; cytokines; immunology; host defense; risk;
D O I
10.3109/08941939709099598
中图分类号
R61 [外科手术学];
学科分类号
摘要
Sepsis remains a major cause of mortality in surgical intensive care units. Patients who survive the initial shock phase but die weeks later from multiple organ dysfunction still are a challenge to basic and clinical research. We addressed whether fulminant sepsis results in rapid changes (24 h) in the cellular capacity to produce cytokines in whole blood of septic patients on further stimulation after the initial systemic inflammatory response. Interleukin (IL)-6 plasma concentrations from 279 pg/mL to 5979 pg/mL confirmed the presence of a systemic inflammatory response. Anti-inflammatory IL-10 concentrations up to 275 pg/mL were detected, but there was no biologically active tumor necrosis factor-alpha (TNF alpha) detectable (by bioassay) at the time of investigation. On stimulation with Escherichia coli ex vivo, proinflammatory TNF alpha (130 pg/mL), IL-6 (4061 pg/mL), and antiinflammatory IL-10 (711 pg/mL) production were markedly depressed in all patients compared with controls (2339 pg/mL, 50,319 pg/mL, and 9654 pg/mL, respectively). Septic shock resulted in early depression of the capacity for pro-and anti-inflammatory cytokine production. Monitoring of this effect, including its relationship to outcome, may offer a target variable for therapeutic efforts to maintain or restore adequate immune reactions to improve survival.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 31 条
[1]   ACTION OF RECOMBINANT HUMAN INTERLEUKIN-6, INTERLEUKIN-1-BETA AND TUMOR NECROSIS FACTOR-ALPHA ON THE MESSENGER-RNA INDUCTION OF ACUTE-PHASE PROTEINS [J].
ANDUS, T ;
GEIGER, T ;
HIRANO, T ;
KISHIMOTO, T ;
HEINRICH, PC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (05) :739-746
[2]  
[Anonymous], MMWR
[3]  
*APCC SCCM CONS C, 1992, CHEST, V101, P1644
[4]  
AYALA A, 1992, ARCH SURG-CHICAGO, V127, P191
[5]  
BAUE AE, 1975, ARCH SURG-CHICAGO, V110, P779
[6]   CYTOKINES AND THEIR INTERACTIONS WITH OTHER INFLAMMATORY MEDIATORS IN THE PATHOGENESIS OF SEPSIS AND SEPTIC SHOCK [J].
BILLIAU, A ;
VANDEKERCKHOVE, F .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (06) :559-573
[7]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[8]   CIRCULATING INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR IN SEPTIC SHOCK AND EXPERIMENTAL ENDOTOXIN FEVER [J].
CANNON, JG ;
TOMPKINS, RG ;
GELFAND, JA ;
MICHIE, HR ;
STANFORD, GG ;
VANDERMEER, JWM ;
ENDRES, S ;
LONNEMANN, G ;
CORSETTI, J ;
CHERNOW, B ;
WILMORE, DW ;
WOLFF, SM ;
BURKE, JF ;
DINARELLO, CA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (01) :79-84
[9]   THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) - IMMUNOLOGY AND POTENTIAL IMMUNOTHERAPY [J].
DARVILLE, T ;
GIROIR, B ;
JACOBS, R .
INFECTION, 1993, 21 (05) :279-290
[10]   MULTIPLE ORGAN FAILURE - PATHOPHYSIOLOGY AND POTENTIAL FUTURE THERAPY [J].
DEITCH, EA .
ANNALS OF SURGERY, 1992, 216 (02) :117-134